• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Anika Therapeutics Inc. - Common Stock (NQ:ANIK)

    14.46 -0.50 (-3.34%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Mar 10, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 147,338
    Open 14.92
    Bid (Size) 11.89 (100)
    Ask (Size) 15.81 (400)
    Prev. Close 14.96
    Today's Range 14.35 - 15.06
    52wk Range 7.870 - 17.14
    Shares Outstanding 14,828,456
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    ANIKA THERAPEUTICS INC (NASDAQ:ANIK) Delivers Decisive Q4 2025 Earnings Beat, Sparking Share Rally ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Anika To Present at the Canaccord Genuity 2026 Musculoskeletal Conference
    From Anika Therapeutics Inc.
    Via GlobeNewswire

    Performance

    YTD
    +54.7%
    +54.7%
    1 Month
    +41.3%
    +41.3%
    3 Month
    +50.2%
    +50.2%
    6 Month
    +61.7%
    +61.7%
    1 Year
    -12.4%
    -12.4%

    More News

    Read More
    News headline image
    Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026
    From Anika Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    ANIKA INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Reminds Anika Therapeutics Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Anika Stockholders
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Earnings Scheduled For November 5, 2025 ↗
    Via Benzinga
    News headline image
    ANIK INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Anika Therapeutics, Inc.
    From Kirby McInerney LLP
    Via Business Wire
    News headline image
    Anika Therapeutics Announces Leadership Transition
    From Anika Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    ANIK Investigation: Investors Encouraged to Contact Kirby McInerney LLP
    From Kirby McInerney LLP
    Via Business Wire
    News headline image
    Anika Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors ANIK
    From Kirby McInerney LLP
    Via GlobeNewswire
    News headline image
    Anika (ANIK) Q3 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Anika Therapeutics Inc (NASDAQ:ANIK) Reports Q3 2025 Earnings Beat and Positive Regulatory Milestone ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Anika Therapeutics Reports Filing of Final PMA Module for Hyalofast® Cartilage Repair Scaffold and Data from U.S. Pivotal FastTRACK Phase III Study
    From Anika Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025
    From Anika Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    ANIKA INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Reminds Anika Therapeutics Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Anika Stockholders
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    ANIKA (ANIK) ALERT: Bragar Eagel & Squire, P.C. is Investigating Anika Therapeutics, Inc. on Behalf of Anika Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Anika Therapeutics, Inc. – ANIK
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Anika Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    ANIKA ALERT: Bragar Eagel & Squire, P.C. is Investigating Anika Therapeutics, Inc. on Behalf of Anika Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Bragar Eagel & Squire, P.C. Is Investigating Nutex, Anika, Fluor, and Inspire Medical and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire

    Frequently Asked Questions

    Is Anika Therapeutics Inc. - Common Stock publicly traded?
    Yes, Anika Therapeutics Inc. - Common Stock is publicly traded.
    What exchange does Anika Therapeutics Inc. - Common Stock trade on?
    Anika Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Anika Therapeutics Inc. - Common Stock?
    The ticker symbol for Anika Therapeutics Inc. - Common Stock is ANIK on the Nasdaq Stock Market
    What is the current price of Anika Therapeutics Inc. - Common Stock?
    The current price of Anika Therapeutics Inc. - Common Stock is 14.46
    When was Anika Therapeutics Inc. - Common Stock last traded?
    The last trade of Anika Therapeutics Inc. - Common Stock was at 03/10/26 04:00 PM ET
    What is the market capitalization of Anika Therapeutics Inc. - Common Stock?
    The market capitalization of Anika Therapeutics Inc. - Common Stock is 214.42M
    How many shares of Anika Therapeutics Inc. - Common Stock are outstanding?
    Anika Therapeutics Inc. - Common Stock has 214M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.